SMAD2 and non-small cell lung carcinoma: Xu et al. discovered that the lncRNA XIST can promote tumour growth and mediate drug-resistant behaviour in NSCLC by decreasing the nuclear transfer of SMAD2, thus inhibiting pyroptosis by suppressing the transcription of NLRP341.